Genetic testing & counselling for childhood cancer families
Medically reviewed by Dr. Naresh Gundu, Medical Oncologist · Last reviewed June 2026
If your child has been diagnosed with cancer — or if cancer runs in your family and you are worried about your children — you deserve clear answers about genetic testing for child cancer and what it can realistically tell you. This page explains who needs testing, what it involves, and how our team supports families through every step of the process.
- Not every child needs germline testing — your oncologist will tell you if it adds useful information to your child’s care
- Tumour board for every patient — 17 specialists review together, including assessment of genetic risk
- Family genetic counselling — coordinated for the whole family, not just the child with cancer
- 45-minute consultations — enough time to answer every question a worried parent carries
on Panel
Survival Rate*
Treated
(800+ reviews)
What genetic testing for child cancer actually tells you
When a child is diagnosed with cancer, one of the first questions families face is whether genetics played a role — and whether other family members are at risk. Genetic testing for childhood cancer is a medical investigation that looks for inherited changes in DNA that may have contributed to the cancer developing. It is not the same as the molecular testing done on the tumour itself (which analyses what is driving the cancer cells). Germline testing, as it is properly called, looks at the child’s own blood or saliva to see whether a mutation was present from birth.
The most important thing to understand is this: most childhood cancers are not caused by an inherited gene mutation. The large majority arise from spontaneous DNA errors during early development — errors that happen at random and are not passed from parent to child. Germline testing is not a standard part of every childhood cancer workup; it is recommended selectively, when the cancer type, the child’s age at diagnosis, or the family history makes a hereditary cause more likely to be relevant.
If your child’s oncologist does recommend germline testing, it is not because they suspect you caused the cancer. It is because identifying a predisposition mutation — if one exists — changes how the cancer is treated, how closely siblings need to be monitored, and what protective steps parents may want to take for themselves. The information, when it is there, is genuinely useful. The decision to test is always yours to make, in your own time, with full information about what the results might and might not mean.
Childhood cancers most commonly linked to germline testing
A genetic counsellor will assess your child’s full picture — but these are the situations where germline testing most commonly changes clinical decisions.
Retinoblastoma (eye cancer)
The hereditary form of retinoblastoma — caused by a mutation in the RB1 gene — is one of the most well-established examples of a cancer with a clearly inherited form. Children with bilateral (both-eye) retinoblastoma, or with a family history of the condition, are routinely offered germline testing. A positive result means siblings should receive early eye examinations from infancy.
Li–Fréaumeni Syndrome
Caused by changes in the TP53 gene, Li–Fréaumeni syndrome is associated with childhood brain tumours, bone sarcomas, adrenocortical carcinoma, and other cancers. Because this syndrome can affect multiple family members across generations, identifying it in a child opens the possibility of cancer surveillance for parents and siblings — so that any future cancers are caught at the earliest stage.
Wilms Tumour & Beckwith–Wiedemann
Most cases of Wilms tumour (a kidney cancer in young children) are not hereditary. However, children with Beckwith–Wiedemann syndrome, WAGR syndrome, or bilateral Wilms tumour are evaluated for germline mutations. Identifying a predisposition helps determine how intensively the remaining kidney needs to be monitored after treatment, and whether abdominal ultrasounds are warranted for siblings.
DICER1-Associated Tumours
DICER1 syndrome is a relatively recently identified predisposition associated with rare childhood tumours including pleuropulmonary blastoma (a rare lung tumour), cystic nephroma, thyroid tumours, and others. Identifying a DICER1 mutation in a child prompts cascade testing in family members and structured surveillance, because relatives who carry the mutation benefit from knowing before any tumour appears.
Strong Family History of Cancer
Even when a specific childhood cancer type is not one of the classical hereditary forms, a strong family cancer history — multiple relatives with the same cancer, cancers at unusually young ages, or multiple different cancers in one person — may prompt genetic evaluation to look for a hereditary pattern. Family genetic counselling for cancer is as much about reviewing the family tree as it is about any single individual’s test result.
Most Cases: No Inherited Mutation Found
The large majority of childhood cancers — leukemia, most brain tumours, lymphomas, neuroblastoma — will not be linked to a germline mutation when tested. A negative result is genuinely reassuring: it tells the family that the cancer is very unlikely to be hereditary, and that siblings and parents carry no elevated genetic risk from this particular cancer. The search for a cause ends there, and treatment proceeds on its own merits.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You deserve a clear answer, not more uncertainty.
Our consultations are 45 minutes — long enough to go through your family history, explain what genetic testing can and cannot tell you, and map out what makes sense for your child and your family.
How family genetic counselling for cancer works in practice
If your child’s oncologist recommends genetic evaluation — or if you have come to this page because of a worrying family history — here is what the process looks like from your first conversation to family-wide follow-up.
The referral conversation with your oncologist
Genetic evaluation begins with a conversation — not a test. Your child’s oncologist (or the CION tumor board, which reviews every patient’s case) will identify whether the cancer type, the child’s age at diagnosis, the tumour’s characteristics, or the family history suggest that a germline (inherited) mutation may be relevant. If so, a referral to genetic counselling is made. This step does not commit you to testing — it opens a conversation about whether testing would give your family useful information.
The genetic counselling session — building your family history
The first meeting with a genetic counsellor typically takes 60 to 90 minutes. The counsellor will draw a three-generation family tree (called a pedigree) — noting which relatives on both sides of the family have had cancer, what types of cancer, and at what ages. This picture alone is often very informative. Patterns such as the same cancer type appearing in multiple close relatives, or cancers appearing much earlier than typical, or one person developing multiple different cancers across their lifetime, are the signals that point toward a hereditary cause. If the family history is unremarkable, the counsellor may conclude that testing is unlikely to be informative and explain why. If patterns are present, the counsellor will recommend specific testing panels.
The germline panel test — a blood or saliva sample from the child
If testing is recommended and the family decides to proceed, a blood or saliva sample is taken from the child and sent to a specialist genetics laboratory. The sample is analysed against a panel of genes known to be associated with childhood cancer predisposition. Results typically take several weeks. The counsellor will explain in advance exactly which genes are being tested and what a positive or negative result in each one would mean clinically. No result is a complete surprise if the pre-test counselling has been done well.
Interpreting the result — what positive and negative each mean
Results fall into three categories: a clearly pathogenic (harmful) mutation is found; no mutation is found (negative result); or a “variant of uncertain significance” is found, meaning a change in the DNA exists but its clinical impact is not yet clearly established. A positive result does not mean other family members will definitely develop cancer — it means they benefit from knowing and from targeted monitoring. A negative result is genuinely reassuring for most families. A variant of uncertain significance requires ongoing monitoring as the scientific evidence around that specific variant evolves. Your genetic counsellor will explain each scenario in plain language before results arrive, so you are prepared for any outcome.
Cascade testing — extending the conversation to the rest of the family
If a pathogenic mutation is found in the child, the next step is “cascade testing” — offering the same targeted test to first-degree relatives (parents, siblings). Because the specific mutation is already known, cascade testing is faster and less expensive than the initial panel. Parents and siblings who test negative can be reassured. Those who test positive are given a personalised surveillance plan: which tests to have, how frequently, and what signs to watch for. The decision to be tested is always voluntary and personal; the genetic counsellor can help each family member understand their own situation before making that choice.
You are not the first family to carry these questions.
Hear from other parents who came to CION worried about inherited cancer risk — and who left with a clear picture of their family’s situation and a plan for moving forward.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Genetic testing & family counselling for childhood cancer — what parents ask most
What is genetic testing for childhood cancer and does my child need it?
Genetic testing for childhood cancer looks for inherited (germline) mutations — changes in DNA that were present from birth and may have contributed to the cancer developing. Not every child with cancer needs germline testing. It is typically recommended when the child’s cancer type has a known hereditary form, when the child’s age at diagnosis is unusually young for that cancer type, or when there is a pattern of related cancers in close family members. Your child’s oncologist will tell you whether germline testing is clinically appropriate for your situation. At CION, every child’s case is reviewed by a multi-specialist tumor board, which includes the expertise to identify when genetic evaluation adds useful information to the care plan.
What is germline testing for a child and how is it different from tumour testing?
Germline testing looks at DNA from a blood or saliva sample taken from the child — not from the tumour itself. It identifies mutations that are present in every cell of the body from birth, meaning they were inherited from a parent. Tumour testing (also called somatic or molecular testing) analyses DNA from the tumour tissue and looks for mutations that arose only in the cancer cells. A child can have somatic tumour mutations without having any inherited germline mutation — this is the case in the majority of childhood cancers. Germline testing answers the question: ‘Did my child inherit a predisposition to cancer?’ Tumour testing answers: ‘What is driving this specific cancer?’ Both are useful — but for different questions.
What does family genetic counselling for cancer involve?
Family genetic counselling for cancer is a structured conversation — usually with a specialist called a genetic counsellor — that reviews your family’s cancer history, explains what genetic testing can and cannot tell you, helps you decide whether testing is right for your family, and interprets the results if testing is done. The first session typically takes 60 to 90 minutes and does not require any testing commitment. The counsellor will map out which relatives on both sides have had cancer, at what ages, and look for patterns that suggest a hereditary predisposition. The outcome is a clear, personalised explanation of your family’s risk picture, a recommendation on whether testing is warranted, and — if a mutation is found — a plan for monitoring family members who may also carry it.
Which childhood cancers are most commonly linked to inherited gene mutations?
A small but important subset of childhood cancers is associated with known genetic predisposition syndromes. Retinoblastoma — a cancer of the retina — has a well-established hereditary form caused by mutations in the RB1 gene, especially when it affects both eyes. Li–Fréaumeni syndrome (TP53 mutations) is linked to several childhood cancers including brain tumours, bone sarcomas, and adrenocortical carcinoma. DICER1 syndrome is associated with rare lung, kidney, and thyroid tumours in children. Beckwith–Wiedemann syndrome raises risk for Wilms tumour (kidney cancer) and hepatoblastoma. Children with Down syndrome have an elevated risk of certain leukemias. These are well-studied examples, not an exhaustive list. A genetic counsellor can assess whether your child’s specific cancer type and family history warrant further evaluation.
If a genetic mutation is found in my child, does that mean the rest of my family has it too?
Finding a germline mutation in your child means that one or both parents likely carry the same mutation, because germline mutations are inherited — they come from egg or sperm. However, not everyone who carries the mutation will develop cancer. The next step after a positive finding in the child is “cascade testing” — offering the same genetic test to parents and, based on those results, to siblings and other close relatives. Each family member’s result is their own private information, and testing is always a personal decision. A genetic counsellor will explain what the specific mutation means for each relative: the level of cancer risk it carries, whether there are effective screening strategies, and whether any preventive steps are available. The goal is to turn uncertainty into actionable information.
Can genetic testing give a definitive answer about why my child got cancer?
Genetic testing can tell you whether an inherited predisposition mutation is present — but it cannot always explain exactly why cancer developed in your child. Even when a predisposition mutation is found, carrying that mutation is only one factor; most people who carry such mutations do not develop cancer. In the majority of childhood cancer cases, no germline mutation is found, which does not mean the test failed — it means your child’s cancer is most likely not hereditary, and siblings and parents carry no elevated inherited risk. If testing does not find a mutation, the cancer’s cause remains the same as for most childhood cancers: spontaneous DNA errors during early development, which are not passed on and are not anyone’s fault.
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.